advertisement

WGA Rescources

Cai W 9

Showing records 1 to 9 | Display all abstracts from Cai W

80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Sheng L
Marine drugs 2019; 17:
81259 Efficacy and Safety of Argon Laser Peripheral Iridoplasty and Systemic Medical Therapy in Asian Patients with Acute Primary Angle Closure: A Meta-Analysis of Randomized Controlled Trials
Cai W; Lou Q
Journal of Ophthalmology 2019; 2019: 7697416
80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Lu B; Chen H
Marine drugs 2019; 17:
81259 Efficacy and Safety of Argon Laser Peripheral Iridoplasty and Systemic Medical Therapy in Asian Patients with Acute Primary Angle Closure: A Meta-Analysis of Randomized Controlled Trials
Fan J; Yu D
Journal of Ophthalmology 2019; 2019: 7697416
80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Du Y; Chen C
Marine drugs 2019; 17:
81259 Efficacy and Safety of Argon Laser Peripheral Iridoplasty and Systemic Medical Therapy in Asian Patients with Acute Primary Angle Closure: A Meta-Analysis of Randomized Controlled Trials
Shen T
Journal of Ophthalmology 2019; 2019: 7697416
80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Cai W
Marine drugs 2019; 17:
81259 Efficacy and Safety of Argon Laser Peripheral Iridoplasty and Systemic Medical Therapy in Asian Patients with Acute Primary Angle Closure: A Meta-Analysis of Randomized Controlled Trials
Yu J
Journal of Ophthalmology 2019; 2019: 7697416
80998 Marine-Steroid Derivative 5α-Androst-3β, 5α, 6β-triol Protects Retinal Ganglion Cells from Ischemia⁻Reperfusion Injury by Activating Nrf2 Pathway
Yang Y; Tian X; Huang Z; Chi W; Lin S; Yan G; Yin W
Marine drugs 2019; 17:

Issue 20-3

Change Issue


advertisement

Oculus